COVID-19 acts as a risk modifier for ACS in young Eastern Indian patients without traditional atherosclerotic risk factors, increasing ACS incidence.
Does the peri-COVID era alter the presentation, management, and outcomes of ACS in young Indian patients lacking traditional risk factors compared to the pre-COVID era?
Tasa de eventos absoluta: 0% vs 0%
SARS-COV-2 virus affects the cardiovascular system by various pathophysiological mechanisms. The incidence of Acute coronary syndrome (ACS) seems to be on rise in the peri-covid era. The proinflammatory and prothrombotic milieu is primarily responsible. Traditional atherosclerotic risk factors do not seem to be responsible for this increased incidence of ACS. We chose to test this hypothesis on young Indian population lacking the traditional atherosclerotic risk factors. If established, Covid 19 infection will at least be considered a risk modifier in causing ACS in future. Subsequently, we went on to study the differences in presentation, diagnostic implications, revascularization and management strategies and finally outcomes in ACS patients in the Peri-covid compared to the pre-covid era. To the best of our knowledge, this seems to be the first of its kind study from eastern India.
Dastidar et al. (Sun,) reported a other. COVID-19 acts as a risk modifier for ACS in young Eastern Indian patients without traditional atherosclerotic risk factors, increasing ACS incidence.